Tepoxalin
CAS: 103475-41-8
Ref. 3D-DEA47541
5mg | A consultar | |
10mg | A consultar | |
25mg | A consultar | |
50mg | A consultar | |
100mg | A consultar |
Informação sobre produto
- 1H-Pyrazole-3-propanamide, 5-(4-chlorophenyl)-N-hydroxy-1-(4-methoxyphenyl)-N-methyl-
- 3-(5-(4-Chlorophenyl)-1-(4-methoxyphenyl)-3-pyrazolyl)-N-hydroxy-N-methylpropanamide
- 3-[5-(4-chlorophenyl)-1-(4-methoxyphenyl)-1H-pyrazol-3-yl]-N-hydroxy-N-methylpropanamide
- 5-(4-Chlorophenyl)-N-hydroxy-1-(4-methoxyphenyl)-N-methyl-1H-pyrazole-3-propanamide
- 5-(p-Chlorophenyl)-1-(p-methoxyphenyl)-N-methylpyrazole-3-propionohydroxamic acid
- Orf 20485
- Rwj 20485
- Tepoxalin [USAN:INN]
- Tepoxalina
- Tepoxalina [Spanish]
- Ver mais sinónimos
- Tepoxaline
- Tepoxaline [French]
- Tepoxalinum
- Tepoxalinum [Latin]
- Unii-Tz4Ox61974
- Zubrin
Tepoxalin is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits prostaglandin synthesis by blocking the cyclooxygenase enzyme. It is used to treat bowel disease and autoimmune diseases, as well as for the prevention of bowel disease in patients with inflammatory bowel disease. Tepoxalin has been shown to inhibit the production of inflammatory mediators such as tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and nitric oxide in animal models. These effects are due to its inhibition of both COX-1 and COX-2, which are enzymes involved in the synthesis of these mediators. Tepoxalin also shows clinical efficacy in reducing pain and inflammation associated with ophthalmic disorders, such as iritis or corneal ulcers. The toxicological profile includes eye, skin, and respiratory irritation; local tissue damage; immunotoxicity; genotoxicity; carcin
Propriedades químicas
Consulta técnica sobre: 3D-DEA47541 Tepoxalin
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.